These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15108807)

  • 1. Ski and SnoN: negative regulators of TGF-beta signaling.
    Luo K
    Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
    Vignais ML
    Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway].
    Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):233-6. PubMed ID: 12905729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-beta resistance, in primary cutaneous melanoma.
    Boone B; Haspeslagh M; Brochez L
    J Dermatol Sci; 2009 Jan; 53(1):26-33. PubMed ID: 18782659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SnoN co-repressor binds and represses smad7 gene promoter.
    Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
    Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Ski and SnoN co-repressors by anisomycin.
    Vázquez-Macías A; Ruíz-Mendoza AB; Fonseca-Sánchez MA; Briones-Orta MA; Macías-Silva M
    FEBS Lett; 2005 Jul; 579(17):3701-6. PubMed ID: 15967445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling.
    Arndt S; Poser I; Moser M; Bosserhoff AK
    Mol Cell Neurosci; 2007 Apr; 34(4):603-11. PubMed ID: 17292623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
    Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
    Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.
    Zhang F; Lundin M; Ristimäki A; Heikkilä P; Lundin J; Isola J; Joensuu H; Laiho M
    Cancer Res; 2003 Aug; 63(16):5005-10. PubMed ID: 12941827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
    Reed JA; Bales E; Xu W; Okan NA; Bandyopadhyay D; Medrano EE
    Cancer Res; 2001 Nov; 61(22):8074-8. PubMed ID: 11719430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear and cytoplasmic c-Ski differently modulate cellular functions.
    Nagata M; Goto K; Ehata S; Kobayashi N; Saitoh M; Miyoshi H; Imamura T; Miyazawa K; Miyazono K
    Genes Cells; 2006 Nov; 11(11):1267-80. PubMed ID: 17054724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ski and SnoN, potent negative regulators of TGF-beta signaling.
    Deheuninck J; Luo K
    Cell Res; 2009 Jan; 19(1):47-57. PubMed ID: 19114989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
    Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.